Segall Bryant & Hamill’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-130,011
| Closed | -$9.78M | – | 756 |
|
|
2022
Q2 | $9.78M | Buy |
130,011
+38,680
| +42% | +$2.91M | 0.11% | 206 |
|
|
2022
Q1 | $2.45M | Buy |
91,331
+211
| +0.2% | +$5.66K | 0.02% | 416 |
|
|
2021
Q4 | $4.35M | Buy |
91,120
+38,145
| +72% | +$1.82M | 0.04% | 337 |
|
|
2021
Q3 | $3.52M | Buy |
52,975
+1,212
| +2% | +$80.5K | 0.03% | 390 |
|
|
2021
Q2 | $4.04M | Buy |
51,763
+2,824
| +6% | +$220K | 0.04% | 365 |
|
|
2021
Q1 | $4.63M | Sell |
48,939
-497
| -1% | -$47K | 0.05% | 349 |
|
|
2020
Q4 | $6.02M | Sell |
49,436
-907
| -2% | -$111K | 0.07% | 263 |
|
|
2020
Q3 | $4.4M | Buy |
50,343
+36,379
| +261% | +$3.18M | 0.06% | 279 |
|
|
2020
Q2 | $903K | Buy |
13,964
+3,741
| +37% | +$242K | 0.02% | 463 |
|
|
2020
Q1 | $457K | Buy |
10,223
+3,508
| +52% | +$157K | 0.01% | 611 |
|
|
2019
Q4 | $419K | Buy |
+6,715
| New | +$419K | 0.01% | 685 |
|